EM 523

Known as: EM-523, EM523L, Erythromycin, 8,9-didehydro-9-deoxo-6-deoxy-6,9-epoxy- 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
Tachyphylaxis may have contributed to the failure of the motilide ABT-229 [N-ethyl, N-methyl 4'' deoxy erythromycin (EM)-B… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • table 1
Is this relevant?
1997
1997
OBJECTIVE To evaluate the effect of the erythromycin derivative EM523L on gastric emptying and postprandial insulin requirement… (More)
Is this relevant?
1996
1996
We investigated the efficacy and the mechanism of action of EM523L, a nonpeptide motilin agonist (motilide), on the stimulation… (More)
Is this relevant?
1996
1996
Motilin was isolated from acid extracts of the small intestine of chickens by a combination of gel filtration chromatography, ion… (More)
Is this relevant?
1994
1994
EM523L, a newly developed erythromycin derivative, has a powerful motilin-like biologic effect and no antibacterial activity. In… (More)
Is this relevant?
1991
1991
In this study, we investigated the effect of EM-523, one of the erythromycin derivatives, on gastrointestinal motility in… (More)
Is this relevant?
1991
1991
Binding studies with iodinated motilin revealed that in the small intestine motilin receptor density decreased aborally… (More)
Is this relevant?
1990
1990
Erythromycin may stimulate gastrointestinal motor activity via its effect upon motilin receptors. We have studied the ability of… (More)
Is this relevant?
1990
1990
The effect of EM-523 [de(N-methyl)-N-ethyl-8,9-anhydroerythromycin A 6,9-hemiacetal], an erythromycin derivative, on preparations… (More)
Is this relevant?